SE442011B - N-(4-alkanoyloxifenyl)-all-trans-retinamid och komposition for forhindrande av framkallning av kancer i epitelial vevnad - Google Patents

N-(4-alkanoyloxifenyl)-all-trans-retinamid och komposition for forhindrande av framkallning av kancer i epitelial vevnad

Info

Publication number
SE442011B
SE442011B SE7906365A SE7906365A SE442011B SE 442011 B SE442011 B SE 442011B SE 7906365 A SE7906365 A SE 7906365A SE 7906365 A SE7906365 A SE 7906365A SE 442011 B SE442011 B SE 442011B
Authority
SE
Sweden
Prior art keywords
retinamide
trans
composition
prevention
tissue
Prior art date
Application number
SE7906365A
Other languages
English (en)
Swedish (sv)
Other versions
SE7906365L (sv
Inventor
R J Gander
Original Assignee
Johnson & Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson filed Critical Johnson & Johnson
Publication of SE7906365L publication Critical patent/SE7906365L/
Publication of SE442011B publication Critical patent/SE442011B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/20—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by carboxyl groups or halides, anhydrides, or (thio)esters thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/09—Geometrical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7906365A 1978-07-31 1979-07-25 N-(4-alkanoyloxifenyl)-all-trans-retinamid och komposition for forhindrande av framkallning av kancer i epitelial vevnad SE442011B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/929,093 US4310546A (en) 1978-07-31 1978-07-31 Novel retinoids and their use in preventing carcinogenesis

Publications (2)

Publication Number Publication Date
SE7906365L SE7906365L (sv) 1980-02-01
SE442011B true SE442011B (sv) 1985-11-25

Family

ID=25457311

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7906365A SE442011B (sv) 1978-07-31 1979-07-25 N-(4-alkanoyloxifenyl)-all-trans-retinamid och komposition for forhindrande av framkallning av kancer i epitelial vevnad

Country Status (14)

Country Link
US (1) US4310546A (de)
AT (1) AT367032B (de)
BE (1) BE877976A (de)
CA (1) CA1108170A (de)
CH (1) CH644845A5 (de)
DE (1) DE2930923A1 (de)
DK (1) DK324279A (de)
FR (1) FR2432509A1 (de)
GB (1) GB2026493B (de)
IE (1) IE48304B1 (de)
IT (1) IT1162414B (de)
NL (1) NL7905893A (de)
NO (1) NO149999C (de)
SE (1) SE442011B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5456663A (en) * 1984-05-25 1995-10-10 Lemelson; Jerome H. Drugs and methods for treating diseases
US4665098A (en) * 1985-03-28 1987-05-12 Mcneilab, Inc. Pharmaceutical composition of N-(4-hydroxyphenyl) retinamide having increased bioavailability
ES2095207T3 (es) * 1987-12-16 1997-02-16 Pasteur Institut Receptor de acido retinoico y derivados del mismo, adn que codifica cualquiera de las dos sustancias y uso de las proteinas y del adn.
US5235076A (en) * 1991-05-28 1993-08-10 University Of Hawaii Azulenic retinoid compounds, compositions and methods
US5849595A (en) * 1992-10-05 1998-12-15 Alfano; Robert R. Method for monitoring the effects of chemotherapeutic agents on neoplasmic media
US5716982A (en) * 1995-06-07 1998-02-10 Institute Of Materia Medica, An Institute Of The Chinese Academy Of Medical Sciences Retinoids and methods of use of same
US5703130A (en) * 1995-06-07 1997-12-30 Institute Of Materia Medica, An Institute Of The Chinese Academy Of Medical Sciences Chalcone retinoids and methods of use of same
US5968940A (en) * 1995-06-08 1999-10-19 Institute Of Materia Medica Retinoids and methods of use of same
KR100508627B1 (ko) * 2001-05-29 2005-08-17 (주)케비젠 신규한 레티노이드 유도체 및 이의 제조방법 및 그화합물을 함유한 항암제 조성물
DE60234024D1 (de) * 2001-05-29 2009-11-26 Chebigen Co Ltd Neue retinoidderivate und eine pharmazeutische anti-krebs-zusammensetzung, die diese verbindungen enthält
WO2005072091A2 (en) * 2003-12-09 2005-08-11 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Methods for inhibiting hiv and other viral infections by modulating ceramide metabolism
US7566808B2 (en) 2004-02-17 2009-07-28 President And Fellows Of Harvard College Management of ophthalmologic disorders, including macular degeneration
US20080176952A1 (en) * 2004-02-17 2008-07-24 Rando Robert R Management of Ophthalmologic Disorders, Including Macular Degeneration
CA2584845C (en) 2004-12-08 2009-02-17 Sirion Therapeutics, Inc. Methods, assays and compositions for treating retinol-related diseases
KR20060094745A (ko) * 2005-02-25 2006-08-30 (주)나노하이브리드 층상형 금속 수산화물과 레티노익산의 혼성체를 함유하는암치료용 약학적 조성물
TW200829269A (en) * 2007-01-12 2008-07-16 Koyo Internat Holding Corp Methods for the cultivation of DC/D-CIK cells and applications
CN101591280B (zh) * 2008-05-30 2012-08-22 安徽医科大学 具有肿瘤诱导分化作用的类维甲酸衍生物及其药物组合物与用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH529742A (de) * 1970-02-02 1972-10-31 Hoffmann La Roche Verfahren zur Herstellung von Vitamin-A-Säureamiden
DE2300107C2 (de) * 1973-01-03 1982-03-11 Basf Ag, 6700 Ludwigshafen Vitamin A-Säureanilid-4-carbonsäureäthylester, Verfahren zu seiner Herstellung und diesen enthaltende Zubereitungen
US4108880A (en) * 1975-11-03 1978-08-22 Johnson & Johnson Esters of retinoic acid

Also Published As

Publication number Publication date
AT367032B (de) 1982-05-25
GB2026493A (en) 1980-02-06
FR2432509B1 (de) 1984-03-30
IT1162414B (it) 1987-04-01
CH644845A5 (de) 1984-08-31
US4310546A (en) 1982-01-12
SE7906365L (sv) 1980-02-01
NO792507L (no) 1980-02-01
DK324279A (da) 1980-02-01
BE877976A (fr) 1980-01-30
GB2026493B (en) 1982-09-29
ATA522979A (de) 1981-10-15
IT7949884A0 (it) 1979-07-27
NO149999B (no) 1984-04-24
NO149999C (no) 1984-08-01
CA1108170A (en) 1981-09-01
FR2432509A1 (fr) 1980-02-29
IE791441L (en) 1980-01-31
DE2930923A1 (de) 1980-02-21
NL7905893A (nl) 1980-02-04
IE48304B1 (en) 1984-11-28

Similar Documents

Publication Publication Date Title
SE442011B (sv) N-(4-alkanoyloxifenyl)-all-trans-retinamid och komposition for forhindrande av framkallning av kancer i epitelial vevnad
US4323581A (en) Method of treating carcinogenesis
US5736576A (en) Method of treating malignant tumors with thyroxine analogues having no significant hormonal activity
EP0600949B1 (de) Neue 3,5-di-tert.butyl-4-hydroxyphenyl-derivate, verfahren zu ihrer herstellung und arzneimittel
US3809714A (en) Novel ester of ((methylamino)methyl) benzyl alcohol
EP0140243B1 (de) Phenoxypropanolamine
US7915303B2 (en) Glycopyrronium salts and their therapeutic use
KR850000065B1 (ko) 린코마이신 및 클린다마이신의 제조방법
JP2023520668A (ja) 薬物二量体を含むナノ粒子、及びその使用
EP0051819A2 (de) Tetra-substituierte Benzolderivate, deren Herstellung und pharmazeutische Präparate damit
IL193774A (en) Pharmaceutical compositions containing a 3,5-seco-4-norcholestane derivative
CA2373603A1 (en) Novel diphenylethylene compounds
US4675341A (en) [(5,6-dichloro-3-oxo-9a-propyl-2,3,9,9a-tetrahydrofluoren-7-yl)oxy]ethanol and its derivatives
US4950686A (en) Anti-mycoplasma agent
BR9814053B1 (pt) diésteres lipofìlicos de agentes de quelação.
US4719310A (en) Ester and amide substituted (2,3-dihydro-4-(3-oxo-1-cyclohexen-1-yl)phenoxy)alkanoic acids and their salts
DE69320367T2 (de) Therapeutische verbindungen für die behandlung von krankheiten, die mit einem glutathion-defizit assoziiert sind, herstellungsprozess und diese enthaltene pharmazeutische zusammensetzungen
EP0004522B1 (de) Neue dilignolähnliche Verbindungen, dilignolähnliche Verbindungen zur Verwendung bei der Behandlung von Lebererkrankungen sowie diese enthaltende pharmazeutische Präparate
LU84062A1 (fr) Esters de mercaptoacyl-carnitines,procede pour leur preparation et leurs utilisations therapeutiques,notamment dans le traitement des intoxications et des brulures et en tant qu'agents mucolytiques
JP2000514412A (ja) 神経毒性損傷の処置のためのバックミンスターフラーレンの使用
WO2001000621A1 (fr) Derives d'ammonium quaternaire, leur procede de preparation et leur usage en pharmacie
EP0006217B1 (de) Substituierte Aminoalkansäuren, ihre Verwendung und Herstellung und sie enthaltende Arzneimittel
US5698585A (en) Pharmaceutical preparation for prevention and/or treatment for cataract
US4472424A (en) Esters of 2-thenoylmercaptopropionylglycine with substituted hydroxybenzenes, process for their preparation and pharmaceutical compositions containing same
DE10201228A1 (de) 10-Benzyliden-9(10H)anthracenone als neue Inhibitoren der Tubulinpolymerisation

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7906365-7

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7906365-7

Format of ref document f/p: F